87787-08-4

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 8-Methyl-1,4-dioxaspiro[4.5]decane-8-carboxylate is used as a key building block for the synthesis of various organic compounds, particularly in the development of new drugs and biologically active molecules. Its unique spirocyclic structure and reactivity contribute to the creation of innovative pharmaceutical agents.
Used in Organic Synthesis:
In the field of organic synthesis, Methyl 8-Methyl-1,4-dioxaspiro[4.5]decane-8-carboxylate is employed as a valuable intermediate for the preparation of a wide range of organic compounds. Its versatile structure allows for various chemical reactions, facilitating the synthesis of complex molecules with potential applications in different industries.
Used in Drug Development:
Methyl 8-Methyl-1,4-dioxaspiro[4.5]decane-8-carboxylate is utilized in drug development as a precursor for the creation of new pharmaceutical agents. Its unique structure and reactivity enable the design and synthesis of novel drug candidates with potential therapeutic benefits.

Upstream product

• 37480-41-4 methyl 1-methyl-4-oxo-1-cyclohexanecarboxylate 
• 26845-47-6 methyl 1,4-dioxaspiro[4.5]decane-8-carboxylate 
• 74-88-4 methyl iodide 
• 67-56-1 methanol 
• 412293-42-6 8-methyl-1,4-dioxaspiro[4.5]decane-8-carboxylic acid 
• 6297-22-9 4-carbomethoxycyclohexanone 

Relevant academic research and scientific papers

2,3-DIHYDRO-1H-PYRROLIZINE-7-FORMAMIDE DERIVATIVE AND APPLICATION THEREOF

The present application relates to a 2,3-dihydro-1H-pyrrolizine-7-formamide derivative as a nucleoprotein inhibitor and a use in preparation of a drug for treating HBV related diseases. The present application specifically relates to a compound represented by formula (II), and isomers or pharmaceutically acceptable salts thereof.

PYRAZOLE CARBOXAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE

Provided herein are compounds of formula (AA): N N H HN O N N R R 6 A (R a ) p, (AA) stereoisomers or a pharmaceutically acceptable salt thereof, wherein A, R a, p, R and R 6 are defined herein, compositions including the compounds and methods of manufacturing and using the compounds for the treatment of diseases.

NITROGENOUS FIVE-MEMBERED RING COMPOUNDS

The present invention is to provide an aliphatic nitrogen-containing 5-membered ring compound represented by the formula [I] : wherein symbols in the formula have the following meanings;A: -CH2- or -S-,B: CH or N,R1: H, a lower alkyl group, etc.,X: a single bonding arm, -CO-, -Alk-CO-, -COCH2-, -Alk-O-, -O-CH2-, -SO2-, -S-, -COO-, -CON(R3)-, -Alk-CON(R3)-, -CON(R3)CH2-, -NHCH2-, etc.,R3: hydrogen atom or a lower alkyl group,Alk: a lower alkylene group, andR2: (1) a cyclic group which may be substituted, (2) a substituted amino group, etc., provided that when X is -CO-, then B is N, or a pharmaceutically acceptable salt thereof.

Thiazolidine derivatives and production thereof

A thiazolidine derivative of the general formula, STR1 is a cyclohexane ring having an oxo or hydroxyl group as a substituent on any of the methylene groups constituting the ring and R is a hydrogen atom or a lower alkyl group having 1 to 4 carbon atoms,